ABACUS phase I and II
ABACUS phase I (2016-2019) explored antibiotic use and access practices in 6 LMICs and revealed the importance of a context and cultural tailored approach to address responsible antibiotic use in each country. During phase I, we also found out that the distinction between antibiotics and other drugs can be challenging.
ABACUS phase II (2020-2020) builds on findings from phase I and aims to investigate the idea of an harmonised physical appearance of antibiotics to facilitate identification from patients and health care professionals.
Funding
Wellcome Trust
Duration
Phase I: 3 years Phase II: 2 years
Principal Investigator
Prof. Heiman Wertheim
International Collaboration Partners in Africa, Asia and Europe
2016: Start of ABACUS phase I
2019: End of ABACUS phase I
2020: Start of ABACUS phase II
2022: Expected end of ABACUS phase II
ABACUS project 